E-LIB Suche - Ergebnisse für: Burggraaf, B. (Benjamin)

1

A placebo-controlled proof-of-concept study of alirocumab o..:

Burggraaf, B (Benjamin) ; Pouw, NMC ; Arroyo, SF...
Burggraaf , B , Pouw , NMC , Arroyo , SF , Van der Zee - van Vark , L , Geijn , GJ , Birnie , E , Huisbrink , J , van der Zwan , EM , Mulder , M , Rensen , PCN , de Herder , W W & Cabezas , MC 2020 , ' A placebo-controlled proof-of-concept study of alirocumab on postprandial lipids and vascular elasticity in insulin-treated patients with type 2 diabetes mellitus ' , Diabetes, Obesity and Metabolism , vol. 22 , no. 5 , pp. 807-816 . https://doi.org/10.1111/dom.13960. , 2020

Link: https://pure.eur.nl/en/p..

2

A placebo-controlled proof-of-concept study of alirocumab o..:

Burggraaf, B. (Benjamin) ; Pouw, N.M.C. (Nadine M.C.) ; Arroyo, S.F. (Salvador Fernández)...
http://repub.eur.nl/pub/124289. , 2020

Link: http://repub.eur.nl/pub/..

3

Is it time to break the fast?-a paradigm shift in clinical ..:

Castro Cabezas, M. (Manuel) ; Burggraaf, B. (Benjamin) ; Klop, B. (Boudewijn)
http://repub.eur.nl/pub/94940. , 2016

Link: http://repub.eur.nl/pub/..

4

Reduced Fasting And Postprandial Triglyceride Levels By Ali..:

Burggraaf, B. ; Pouw, N. ; Arroyo, S. Fernandez...
Atherosclerosis. 287 (2019) - p. e44 , 2019

Link: https://doi.org/10.1016/..

5

Systemic Erythrocyte-Bound Apolipoprotein B In Diabetes:

Burggraaf, B. ; van der Meulen, N. ; van der Geijn, G.J..
Atherosclerosis. 287 (2019) - p. e128 , 2019

Link: https://doi.org/10.1016/..

6

A placebo‐controlled proof‐of‐concept study of alirocumab o..:

Burggraaf, Benjamin ; Pouw, Nadine M.C. ; Arroyo, Salvador Fernández...
Diabetes, Obesity and Metabolism. 22 (2020) 5 - p. 807-816 , 2020

Link: https://doi.org/10.1111/..

7

Effect of Vitamin D3 on the Postprandial Lipid Profile in O..:

Fernández-Arroyo, Salvador ; Hernández-Aguilera, Anna ; de Vries, Marijke A....
Nutrients. 11 (2019) 5 - p. 1194 , 2019

Link: https://doi.org/10.3390/..

8

Dyslipidemias in clinical practice:

Castro Cabezas, Manuel ; Burggraaf, Benjamin ; Klop, Boudewijn
Clinica Chimica Acta. 487 (2018) - p. 117-125 , 2018

Link: https://doi.org/10.1016/..

9

Progression of subclinical atherosclerosis in subjects with..:

Burggraaf, Benjamin ; van Breukelen – van der Stoep, Deborah F. ; de Vries, Marijke A....
Atherosclerosis. 271 (2018) - p. 84-91 , 2018

Link: https://doi.org/10.1016/..

10

Increased NEFA levels reduce blood Mg2+ in hypertriacylglyc..:

Kurstjens, Steef ; de Baaij, Jeroen H. F. ; Overmars-Bos, Caro...
Diabetologia. 62 (2018) 2 - p. 311-321 , 2018

Link: https://doi.org/10.1007/..

11

Evidence for increased chylomicron remnants in rheumatoid a..:

Burggraaf, Benjamin ; van Breukelen‐van der Stoep, Deborah F. ; van Zeben, Jendé...
European Journal of Clinical Investigation. 48 (2018) 2 - p. , 2018

Link: https://doi.org/10.1111/..

12

Does the presence of metabolic syndrome affect progression ..:

Burggraaf, Benjamin ; Van Breukelen, Deborah ; De Vries, Marijke...
Atherosclerosis. 263 (2017) - p. e97 , 2017

Link: https://doi.org/10.1016/..

13

Interventions in type 2 diabetes mellitus and cardiovascula..:

Burggraaf, Benjamin ; Castro Cabezas, Manuel
European Journal of Internal Medicine. 42 (2017) - p. 1-15 , 2017

Link: https://doi.org/10.1016/..

14

Lesional skin of seborrheic dermatitis patients is characte..:

Rousel, Jannik ; Nădăban, Andreea ; Saghari, Mahdi...
Experimental Dermatology. 33 (2023) 1 - p. , 2023

Link: https://doi.org/10.1111/..

15

Treatment with the Topical Antimicrobial Peptide Omiganan i..:

Rousel, Jannik ; Saghari, Mahdi ; Pagan, Lisa...
International Journal of Molecular Sciences. 24 (2023) 18 - p. 14315 , 2023

Link: https://doi.org/10.3390/..